Flywheel, a Minneapolis, US-based leading biomedical research data management platform, raised $22 million in a Series C funding round.
The funding round is led by 8VC, which is focused on building technology platforms that create long-term economic and societal value. Other investors include iSelect, Argonautic Ventures, Beringea, DrX/Novartis, HPE Pathfinder, Spike Ventures, Key Investments, Seraph, Great North Labs, and others.
Flywheel can now offer additional research workflow solutions and clinical applications to accelerate R&D and scientific discovery, plus an expanded global network of innovators with even more opportunities for biomedical research collaboration.
Company: Flywheel Exchange LLC
Round: Series C
Funding Month: September 2021
Lead Investors: 8VC
Additional Investors: iSelect, Argonautic Ventures, Beringea, DrX/Novartis, HPE Pathfinder, Spike Ventures, Key Investments, Seraph, Great North Labs, and others
Company Website: https://flywheel.io/
Software Category: Biomedical research data management platform
About the Company: Flywheel is the revolutionary research data management platform powering healthcare innovation by accelerating collaboration, enabling machine learning, and streamlining the massive task of data aggregation, curation, and management. By leveraging cloud scalability and automating research workflows, Flywheel helps organizations scale research data and analysis, improve scientific collaboration and accelerate discoveries. Flywheel offers comprehensive solutions for life sciences, pharmaceutical, biotech, academic, and clinical research. Flywheel is headquartered in Minneapolis and has offices in the Bay Area, St. Louis, and Budapest